Neurocrine Biosciences Cash Flow Statement (2010-2026) | NBIX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
42.30M22.50M-7.30M13.90M-16.90M68.50M89.00M-76.60M95.50M83.10M147.70M43.40M65.00M129.80M103.10M7.90M107.50M209.50M153.70M197.90M
Depreciation and Depletion (Quarter)
2.60M2.80M3.00M3.30M3.90M4.00M3.90M4.10M4.20M4.60M4.90M5.30M6.40M5.60M6.20M6.60M6.30M6.70M6.40M7.20M
Share-based Compensation (Quarter)
28.60M37.10M35.60M37.00M49.50M43.10M43.50M39.90M68.50M47.80M38.10M44.50M43.10M41.50M66.40M52.80M52.80M53.70M58.60M57.20M
Deferred Taxes (Quarter)
9.50M5.70M-4.70M-0.30M-3.10M9.00M13.50M-31.60M-41.50M-4.20M20.60M-15.60M-41.30M-34.90M-31.30M-13.70M-37.40M168.30M48.20M-61.10M
Gains from Investment Securities (Quarter)
5.60M1.80M199.00M262.60M3.40M-3.40M55.70M
Non-cash Items (Quarter)
Change in Working Capital (Quarter)
Cash from Operations (Quarter)
103.20M61.80M4.20M-40.50M138.10M98.80M143.00M-125.20M179.60M212.00M123.50M130.30M64.60M158.00M242.50M64.80M102.00M227.50M388.40M145.80M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
4.00M4.20M4.10M-3.70M0.90M5.10M6.00M-8.50M0.90M13.20M-11.40M23.50M1.00M1.00M8.70M-6.60M1.30M
Amortization of Deferred Charges (Quarter)
0.30M0.20M0.30M0.40M0.40M0.20M0.20M0.20M0.20M0.20M0.10M
Depreciation & Amortization (CF) (Quarter)
2.60M2.80M3.00M3.30M3.90M4.00M3.90M4.10M4.20M4.60M4.90M5.30M6.40M5.60M6.20M6.60M6.30M6.70M6.40M7.20M
Change in Working Capital
Change in Receivables (Quarter)
10.70M5.30M21.70M78.00M15.50M22.20M46.50M41.70M-4.20M30.40M21.40M11.30M17.60M12.90M-2.00M36.90M79.70M132.30M-38.40M81.40M
Change in Inventory (Quarter)
-1.80M-2.80M5.00M-1.50M0.30M7.70M-3.90M-1.80M-1.60M-2.90M0.90M-1.10M5.30M3.30M11.60M1.70M-2.10M12.30M3.40M-4.30M
Change in Accured Expenses (Quarter)
18.00M8.70M19.10M11.50M32.70M32.80M37.60M6.70M16.20M124.40M-98.30M-18.60M-59.50M44.20M77.30M-3.00M30.90M55.80M76.50M-14.30M
Change in Taxes (Quarter)
55.10M15.40M35.50M119.80M
Other Working Capital Changes (Quarter)
3.00M16.10M-12.50M0.80M1.50M0.70M14.20M24.30M-24.60M4.10M-3.10M3.40M-3.40M54.00M0.70M-0.20M16.10M27.80M31.40M
Investing Activities
Capital Expenditures (Quarter)
-2.30M12.30M-12.60M7.60M8.80M-15.70M15.80M0.60M14.70M-14.40M27.40M1.10M21.70M8.10M7.30M10.70M12.50M-22.60M33.40M9.10M
Sales of Property, Plant and Equipment (Quarter)
Divestments (Quarter)
63.20M
Change in Acquisitions & Divestments (Quarter)
202.90M159.70M174.00M176.50M101.10M71.20M162.20M203.90M204.70M273.00M290.80M276.30M175.10M265.30M250.80M298.10M298.60M225.00M267.70M259.20M
Cash from Investing Activities (Quarter)
-90.80M-126.20M23.70M-31.60M31.40M-61.30M-115.60M-42.10M-125.90M-97.30M-201.80M-55.00M-28.20M24.70M-68.30M14.20M-29.00M-196.70M-52.90M-506.20M
Financing Activities
Cash from Financing Activities (Quarter)
3.00M7.50M1.80M6.10M-276.40M11.40M24.60M8.20M2.90M18.80M35.40M69.90M-293.00M26.40M-290.00M-117.90M-3.30M45.60M37.30M-86.10M
Additional items
Exchange Rate Effect (Quarter)
0.30M0.30M-0.30M-0.20M
Change in Cash (Quarter)
15.40M-56.90M29.70M-66.00M-106.90M48.90M50.70M-159.10M56.60M133.50M-42.60M145.20M-256.60M209.40M-116.10M-38.90M69.90M76.20M372.80M-446.50M
Free Cash Flow (Quarter)
105.50M49.50M16.80M-48.10M129.30M114.50M127.20M-125.80M164.90M226.40M96.10M129.20M42.90M149.90M235.20M54.10M89.50M250.10M355.00M136.70M
Net Cash Flow (Quarter)
15.40M-56.90M29.70M-66.00M-106.90M48.90M52.00M-159.10M56.60M133.50M-42.90M145.20M-256.60M209.10M-115.80M-38.90M69.70M76.40M372.80M-446.50M